Newsbenzinga
Quest Diagnostics Raises FY2026 GAAP EPS Guidance from $9.97-$10.17 to $10.21-$10.31 vs $10.15 Est
· Published
Article summary
Please check the source for details.
An excerpt from the original article.Please check the source for details.
An excerpt from the original article.
Comments —
Loading comments…